Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3913]
News [11356]
Articles [47]
Editorials [10]
Conferences [196]
elearning [4]
FDA approves ribociclib with an aromatase inhibitor and ribociclib and letrozole co-pack for early high-risk breast cancer
FDA approves ribociclib with an aromatase inhibitor and ribociclib and letrozole co-pack for early high-risk...
Proteins in meat, milk, and other foods suppress gut tumours
Proteins in meat, milk, and other foods suppress gut tumours
WCLC 2024: Dexamethasone reduces infusion-related reactions in patients with EGFR-mutated non-small cell lung cancer treated with intravenous amivantamab-vmjw
WCLC 2024: Dexamethasone reduces infusion-related reactions in patients with EGFR-mutated non-small cell lung...
ESMO 2024: Encoradenib & binimetinib shows long-term clinically meaningful response in patients with BRAF V600E-mutant metastatic non-small Cell lung cancer
ESMO 2024: Encoradenib & binimetinib shows long-term clinically meaningful response in patients with BRAF V600E...
ESMO 2024: Neoadjuvant TAR-200 plus cetrelimab nearly doubles the pathological complete response rate compared to cetrelimab alone in patients with muscle-invasive bladder cancer
ESMO 2024: Neoadjuvant TAR-200 plus cetrelimab nearly doubles the pathological complete response rate compared to...
Novel triplet regimen yields promising response in advanced-phase chronic myeloid leukaemia
Novel triplet regimen yields promising response in advanced-phase chronic myeloid leukaemia
New research shows how oral cancer cells avoid immune system
New research shows how oral cancer cells avoid immune system
FDA approves pembrolizumab with chemotherapy for unresectable advanced or metastatic malignant pleural mesothelioma
FDA approves pembrolizumab with chemotherapy for unresectable advanced or metastatic malignant pleural mesothelioma
ESMO 2024: Alternating pazopanib bevacizumab regimen doubles progression-free survival in metastatic kidney cancer
ESMO 2024: Alternating pazopanib bevacizumab regimen doubles progression-free survival in metastatic kidney cancer
Inherited changes in BRCA genes linked to increased risk of multiple myeloma
Inherited changes in BRCA genes linked to increased risk of multiple myeloma

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation